Thu, April 4, 2024
Wed, April 3, 2024
Tue, April 2, 2024
Mon, April 1, 2024
Sun, March 31, 2024
Thu, March 28, 2024

Raghuram Selvaraju Maintained (AXSM) at Strong Buy and Held Target at $190 on, Apr 2nd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-190-on-apr-2nd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $190 on, Apr 2nd, 2024.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 9 other peers that have a rating on AXSM. Out of the 9 peers that are also analyzing AXSM, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 9 analyists that currently disagree with Raghuram


  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $109 on, Thursday, March 28th, 2024
  • Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $150 on, Tuesday, March 26th, 2024
  • Leonid Timashev of "RBC Capital" Maintained at Buy with Increased Target to $128 on, Tuesday, March 26th, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Increased Target to $127 on, Tuesday, March 26th, 2024
  • Joel Beatty of "Baird" Initiated at Buy and Held Target at $108 on, Tuesday, March 19th, 2024
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $125 on, Wednesday, February 21st, 2024
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $103 on, Wednesday, February 21st, 2024
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024

Publication Contributing Sources